Jialiang Guo

Dr. Jialiang Guo


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
BYBin Yang
Bin Yang
HYHongyan Yang
Hongyan Yang
JLJianlong Liang
Jianlong Liang
JCJiarou Chen
Jiarou Chen
CWChunhua Wang
Chunhua Wang
JGJialiang Guo
Jialiang Guo
Natural antimicrobial peptides (AMPs) are promising candidates for the development of a new generation of antimicrobials to combat antibiotic-resistant pathogens. They have found extensive applications in the fields of medicine, food, and agriculture. However, efficiently screening AMPs from natural sources poses several challenges, including low efficiency and high antibiotic resistance. This review focuses on the action mechanisms of AMPs, both through membrane and non-membrane routes. We thoroughly examine various highly efficient AMP screening methods, including whole-bacterial adsorption binding, cell membrane chromatography (CMC), phospholipid membrane chromatography binding, membrane-mediated capillary electrophoresis (CE), colorimetric assays, thin layer chromatography (TLC), fluorescence-based screening, genetic sequencing-based analysis, computational mining of AMP databases, and virtual screening methods. Additionally, we discuss potential developmental applications for enhancing the efficiency of AMP discovery. This review provides a comprehensive framework for identifying AMPs within complex natural product systems.

13 June 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RMRong Ma
Rong Ma
DLDanni Lu
Danni Lu
JWJian Wang
Jian Wang
QXQian Xie
Qian Xie
JGJialiang Guo
Jialiang Guo
Chiral drugs generally exhibit differences in activity because they bind differently to their target receptor. The Chinese medicine borneol ('Bing Pian' in Chinese) is a bicyclic monoterpenoid with a wide range of biological activities. Three kinds of Chinese medicines comprising borneol are used clinically, namely, L-Borneolum ('Ai Pian' in Chinese), Borneolum ('Tian Ran Bing Pian' in Chinese), and synthetic borneol ('He Cheng Bing Pian' in Chinese). The three kinds of borneol have different stereochemical configurations, but their clinical uses are nearly identical, and their prices vary widely. However, there is no clear rational basis for the selection of these kinds of borneol in clinical applications. The purpose of this study was to clarify differences in the biological activity, safety, and structure-activity relationship of the three kinds of borneol. 'borneol', 'Bing Pian', 'Ai Pian', 'Tian Ran Bing Pian', and 'He Cheng Bing Pian' were selected as keywords to search for and extract relevant literature in the CNKI, PubMed, and Google Scholar databases up to November 2022. L-borneol has better potential in cerebrovascular diseases. The three kinds of borneol have stronger penetration-promoting effects on hydrophilic drugs. L-borneol and isoborneol promote intestinal mucosal absorption of drugs via bidirectional regulation of P-glycoprotein. D-borneol exhibits better antitumour sensitizing effects than L-borneol. L-borneol exhibits better inhibition of bacterial adhesion because of its C2 chiral centre. Synthetic borneol is less safe. L-borneol has excellent potential in many aspects, has various sources, and can effectively replace expensive D-borneol in some applications.

29 October 2022 in Food Chemistry
Verified
Journal Article
Closed access
TZTing Zhao
Ting Zhao
XLXiaochen Liang
Xiaochen Liang
XGXinjie Guo
Xinjie Guo
XYXingjie Yang
Xingjie Yang
JGJialiang Guo
Jialiang Guo
HZHaibo Zhou
Haibo Zhou

5 December 2017 in MedChemComm
Verified
Journal Article
Closed access
PDF file
JZJun-Xia Zheng
Jun-Xia Zheng
YHYu-Shui Han
Yu-Shui Han
JWJin-Cai Wang
Jin-Cai Wang
HYHui Yang
Hui Yang
HKHao Kong
Hao Kong
PSPing-Hua Sun
Ping-Hua Sun
Strigolactones (SLs) are a novel class of plant hormones with enormous potential for the prevention and treatment of inflammation. To further investigate the anti-inflammatory activities of SLs, a representative SL, GR24, and the reductive products of its D-ring were synthesized and their anti-inflammatory activities were fully evaluated on both in vitro and in vivo models. Among these compounds, the two most active optical isomers (2a and 6a) demonstrated strong inhibitory activity on the release of inflammatory cytokines, including nitric oxide (NO), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) by blocking the nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways; they also greatly inhibited the migration of neutrophils and macrophages in fluorescent protein labeled zebrafish larvae. These results identified the promising anti-inflammatory effects of SLs, and suggested that both the absolute configuration of SL and the α,β-unsaturated D-ring structure are essential for the observed anti-inflammatory activity.

23 January 2024 in Molecules
Verified
Journal Article
Open access
PDF file
HYHongyan Yang
Hongyan Yang
RMRong Ma
Rong Ma
JCJiarou Chen
Jiarou Chen
QXQian Xie
Qian Xie
WLWenhui Luo
Wenhui Luo
JGJialiang Guo
Jialiang Guo
The development of antibiotic-resistant microorganisms is a major global health concern. Recently, there has been an increasing interest in antimicrobial peptides as a therapeutic option. This study aimed to evaluate the triple-action (broad-spectrum antibacterial, anti-biofilm, and anti-quorum sensing activities) of melittin, a membrane-active peptide present in bee venom. The minimum inhibitory concentration and minimum bactericidal concentration of the melittin were determined using the microdilution method and agar plate counting. Growth curve analysis revealed that melittin showed a concentration-dependent antibacterial activity. Scanning electron microscope analysis revealed that melittin treatment altered the morphology. Confocal laser scanning microscope revealed that melittin increased the membrane permeability and intracellular ROS generation in bacteria, all of which contribute to bacterial cell death. In addition, the crystal violet (CV) assay was used to test the anti-biofilm activity. The CV assay demonstrated that melittin inhibited biofilm formation and eradicated mature biofilms. Biofilm formation mediated by quorum sensing (QS) plays a major role in this regard, so molecular docking and molecular dynamics analysis confirmed that melittin interacts with LasR receptors through hydrogen bonds, and further evaluates the anti-QS activity of melittin through the production of virulence factors (pyocyanin, elastase, and rhamnolipid), exopolysaccharides secretion, and bacterial motility, that may be the key to inhibiting the biofilm formation mechanism. The present findings highlight the promising role of melittin as a broad-spectrum antibacterial, anti-biofilm agent, and potential QS inhibitor, providing a new perspective and theoretical basis for the development of alternative antibiotics.

4 April 2019 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
HLHang Lin
Hang Lin
CZChangfa Zhang
Changfa Zhang
YLYuanjing Lin
Yuanjing Lin
YCYiqun Chang
Yiqun Chang
JCJacques Crommen
Jacques Crommen
JGJialiang Guo
Jialiang Guo